These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26976353)

  • 21. The auspicious role of the 5-HT3 receptor in depression: a probable neuronal target?
    Rajkumar R; Mahesh R
    J Psychopharmacol; 2010 Apr; 24(4):455-69. PubMed ID: 20123937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of 5HT3 and HT4 receptor expression in HT29 cell line and human colon adenocarcinoma tissues.
    Ataee R; Ajdary S; Rezayat M; Shokrgozar MA; Shahriari S; Zarrindast MR
    Arch Iran Med; 2010 Mar; 13(2):120-5. PubMed ID: 20187666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects.
    Mahar I; Bambico FR; Mechawar N; Nobrega JN
    Neurosci Biobehav Rev; 2014 Jan; 38():173-92. PubMed ID: 24300695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The rapid recovery of 5-HT cell firing induced by the antidepressant vortioxetine involves 5-HT(3) receptor antagonism.
    Bétry C; Pehrson AL; Etiévant A; Ebert B; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2013 Jun; 16(5):1115-27. PubMed ID: 23089374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of antidepressant drugs on the hypothalamic-pituitary-adrenal axis activity and glucocorticoid receptor function.
    Budziszewska B
    Pol J Pharmacol; 2002; 54(4):343-9. PubMed ID: 12523487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antidepressant-like effect of geniposide on chronic unpredictable mild stress-induced depressive rats by regulating the hypothalamus-pituitary-adrenal axis.
    Cai L; Li R; Tang WJ; Meng G; Hu XY; Wu TN
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1332-41. PubMed ID: 25914157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function.
    Nikisch G
    Neuro Endocrinol Lett; 2009 Mar; 30(1):11-6. PubMed ID: 19300389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of neurotransmitter receptors by desipramine and other antidepressant drugs: the neurotransmitter receptor hypothesis of antidepressant action.
    Stahl SM
    J Clin Psychiatry; 1984 Oct; 45(10 Pt 2):37-45. PubMed ID: 6090439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-depressant-like activity of a novel serotonin type-3 (5-HT3) receptor antagonist in rodent models of depression.
    Gupta D; Devadoss T; Bhatt S; Gautam B; Jindal A; Pandey D; Mahesh R
    Indian J Exp Biol; 2011 Aug; 49(8):619-26. PubMed ID: 21870430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutamate system as target for development of novel antidepressants.
    Catena-Dell'Osso M; Fagiolini A; Rotella F; Baroni S; Marazziti D
    CNS Spectr; 2013 Aug; 18(4):188-98. PubMed ID: 23369807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5HT1A receptors and pharmacotherapy. Is serotonin receptor down-regulation linked to the mechanism of action of antidepressant drugs?
    Stahl S
    Psychopharmacol Bull; 1994; 30(1):39-43. PubMed ID: 7972628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological basis of depression and therapeutic relevance.
    Richelson E
    J Clin Psychiatry; 1991 Jun; 52 Suppl():4-10. PubMed ID: 1646793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antidepressant drugs and central monoaminergic receptors].
    Asakura M; Tsukamoto T
    Yakubutsu Seishin Kodo; 1985 Dec; 5(4):303-19. PubMed ID: 2870595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for the involvement of the serotonergic 5-HT2A/C and 5-HT3 receptors in the antidepressant-like effect caused by oral administration of bis selenide in mice.
    Jesse CR; Wilhelm EA; Bortolatto CF; Nogueira CW
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):294-302. PubMed ID: 19961893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular and cellular mechanisms of antidepressant drugs.
    Owens MJ
    Depress Anxiety; 1996-1997; 4(4):153-9. PubMed ID: 9166647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effects of a novel 5-HT3 receptor antagonist, N-n-butyl-3-methoxy quinoxaline-2-carboxamide (6o) against chronic unpredictable mild stress-induced behavioral changes and biochemical alterations.
    Bhatt S; Mahesh R; Jindal A; Devadoss T
    Pharmacol Biochem Behav; 2014 Jul; 122():234-9. PubMed ID: 24769308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies for producing faster acting antidepressants.
    Adell A; Castro E; Celada P; Bortolozzi A; Pazos A; Artigas F
    Drug Discov Today; 2005 Apr; 10(8):578-85. PubMed ID: 15837601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression.
    Koike H; Fukumoto K; Iijima M; Chaki S
    Behav Brain Res; 2013 Feb; 238():48-52. PubMed ID: 23098797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine, depression and antidepressants.
    Dailly E; Chenu F; Renard CE; Bourin M
    Fundam Clin Pharmacol; 2004 Dec; 18(6):601-7. PubMed ID: 15548230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A new concept of antidepressant drugs action: clinical and preclinical data].
    Płaźnik A; Kostowski W
    Psychiatr Pol; 1994; 28(1):39-50. PubMed ID: 7910691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.